{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:56Z","timestamp":1786119296993,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/cej.0b013e32832c3882","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T05:08:13Z","timestamp":1249276093000},"page":"416-423","source":"Crossref","is-referenced-by-count":10,"title":["Effective anti-tumor responses induced by recombinant bacillus Calmette\u2013Gu\u00e9rin vaccines based on different tandem repeats of MUC1 and GM-CSF"],"prefix":"10.1097","volume":"18","author":[{"given":"Shifang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210128","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/PL00006677","article-title":"MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines","volume":"48","author":"Acres","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"R2-13-20210128","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/intimm\/13.7.897","article-title":"Mechanisms of cytokine synergy essential for vaccine protection against viral challenge","volume":"13","author":"Ahlers","year":"2001","journal-title":"Int Immunol"},{"key":"R3-13-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10408360490452040","article-title":"MUC1 and the MUCs: a family of human mucins with impact in cancer biology","volume":"41","author":"Baldus","year":"2004","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R4-13-20210128","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0923-2508(90)90132-A","article-title":"Recombinant BCG as a candidate oral vaccine vector","volume":"141","author":"Barletta","year":"1990","journal-title":"Res Microbiol"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2567.2003.01656.x","article-title":"Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells","volume":"109","author":"Chen","year":"2003","journal-title":"Immunology"},{"key":"R6-13-20210128","first-page":"1280","article-title":"Development and preclinical evaluation of a Bacillus Calmette-Guerin-MUC1-based novel breast cancer vaccine","volume":"63","author":"Chung","year":"2003","journal-title":"Cancer Res"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1182\/blood.V88.1.202.202","article-title":"Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines","volume":"88","author":"Disis","year":"1996","journal-title":"Blood"},{"key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm0597-558","article-title":"Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells","volume":"3","author":"Gong","year":"1997","journal-title":"Nat Med"},{"key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1073\/pnas.95.11.6279","article-title":"Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells","volume":"95","author":"Gong","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/(SICI)1097-0215(19960301)65:5<664::AID-IJC17>3.0.CO;2-7","article-title":"Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells","volume":"65","author":"Graham","year":"1996","journal-title":"Int J Cancer"},{"key":"R11-13-20210128","first-page":"229","article-title":"Efficacy and safety of live recombinant BCG vaccines","volume":"84","author":"Hanson","year":"1995","journal-title":"Dev Biol Stand"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0952-7915(00)00110-2","article-title":"Cytokines and T cells in host defense","volume":"12","author":"Hunter","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yrtph.2007.05.005","article-title":"Pre-clinical safety evaluation of heat shock protein 65\u2013MUC1 peptide fusion protein","volume":"49","author":"Huo","year":"2007","journal-title":"Regul Toxicol Pharm"},{"key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.4049\/jimmunol.158.10.4591","article-title":"Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines","volume":"158","author":"Iwasaki","year":"1997","journal-title":"J Immunol"},{"key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.cej.0000136568.86245.b7","article-title":"Protein biomarkers for breast cancer prevention","volume":"13","author":"Janssens","year":"2004","journal-title":"Eur J Cancer Prev"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.4049\/jimmunol.165.10.5713","article-title":"Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA","volume":"165","author":"Koido","year":"2000","journal-title":"J Immunol"},{"key":"R16-13-20210128","first-page":"2856","article-title":"Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients","volume":"54","author":"Kotera","year":"1994","journal-title":"Cancer Res"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/CEJ.0b013e328011ed98","article-title":"Translational approaches for the prevention of estrogen receptor-negative breast cancer","volume":"16","author":"Li","year":"2007","journal-title":"Eur J Cancer Prev"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14796694.1.1.57","article-title":"Cancer immunoprevention","volume":"1","author":"Lollini","year":"2005","journal-title":"Future Oncol"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.4049\/jimmunol.165.6.3451","article-title":"Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred","volume":"165","author":"Mukherjee","year":"2000","journal-title":"J Immunol"},{"key":"R20-13-20210128","first-page":"3893","article-title":"Antitumor effect of double immunization of mice with mucin 1 and its coding DNA","volume":"25","author":"Mushenkova","year":"2005","journal-title":"Anticancer Res"},{"key":"R22-13-20210128","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.20040","article-title":"Protection against MUC1 expressing mouse tumours by intra-muscular injection of MUC1 cDNA requires functional CD8+and CD4+T cells but does not require the MUC1 tandem repeat domain","volume":"109","author":"Plunkett","year":"2004","journal-title":"Int J Cancer"},{"key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jgm.397","article-title":"Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer","volume":"5","author":"Rochlitz","year":"2003","journal-title":"J Gene Med"},{"key":"R24-13-20210128","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00002371-200009000-00007","article-title":"Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer","volume":"23","author":"Scholl","year":"2000","journal-title":"J Immunother"},{"key":"R25-13-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1745-7270.2007.00281.x","article-title":"Immune responses and protective efficacy induced by 85B antigen and early secreted antigenic target-6 kDa antigen fusion protein secreted by recombinant bacille Calmette-Gu\u00e9rin","volume":"39","author":"Shi","year":"2007","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"R26-13-20210128","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.vaccine.2006.01.014","article-title":"A MUC1\/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice","volume":"24","author":"Snyder","year":"2006","journal-title":"Vaccine"},{"key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.4049\/jimmunol.166.11.6555","article-title":"Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection","volume":"166","author":"Soares","year":"2001","journal-title":"J Immunol"},{"key":"R28-13-20210128","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"key":"R29-13-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1020360121451","article-title":"MUC1 and the immunobiology of cancer","volume":"7","author":"Taylor-P","year":"2002","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.4049\/jimmunol.161.10.5500","article-title":"CD4+lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice","volume":"161","author":"Tempero","year":"1998","journal-title":"J Immunol"},{"key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.4049\/jimmunol.161.5.2325","article-title":"A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine","volume":"161","author":"Weiss","year":"1998","journal-title":"J Immunol"},{"key":"R32-13-20210128","first-page":"3575","article-title":"MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer","volume":"25","author":"Yamamoto","year":"2005","journal-title":"Anticancer Res"},{"key":"R33-13-20210128","first-page":"3315","article-title":"Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice","volume":"56","author":"Zhang","year":"1996","journal-title":"Cancer Res"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0b013e32832c3882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:55Z","timestamp":1786039195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008469-200909000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0b013e32832c3882","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}